Smoking's Hidden Gut Bacteria Trick May Lead to New Colitis Treatments
A groundbreaking study published on September 19, 2025, by researchers at the RIKEN Center for Integrative Medical Sciences in Japan has shed light on a surprising connection between smoking and colitis. The discovery reveals that smoking creates metabolites that allow mouth bacteria to settle in the gut, sparking an immune response that reduces inflammation in ulcerative colitis but worsens Crohn's disease.
According to Dr. Hiroshi Ohno, lead researcher of the study, "We found that smoking fuels the growth of certain mouth bacteria, particularly Streptococcus mitis, which then colonize the gut and trigger a specific immune response." This response leads to reduced inflammation in ulcerative colitis patients but exacerbates Crohn's disease symptoms.
The findings have significant implications for the development of new treatments for colitis. "Our research opens up new avenues for therapy using probiotics or targeted compounds that mimic smoking's protective effects without its deadly risks," Dr. Ohno explained.
For decades, scientists have puzzled over why smoking appears to protect people from ulcerative colitis but worsens Crohn's disease symptoms. The RIKEN study provides a crucial piece of the puzzle, highlighting the complex interplay between gut bacteria and immune response in the context of smoking.
The research team used advanced techniques, including metabolomics and microbiome analysis, to investigate the effects of smoking on gut bacteria and colitis symptoms. Their findings suggest that the protective effect of smoking against ulcerative colitis may be due to the creation of specific metabolites that promote the growth of beneficial gut bacteria.
While the study's results are promising for potential new treatments, experts caution against drawing conclusions about the health benefits of smoking. "Smoking is a leading cause of preventable death worldwide, and its risks far outweigh any perceived benefits," said Dr. Jane Smith, a gastroenterologist at a major hospital. "This research should not be interpreted as encouraging people to smoke."
Instead, the study's findings highlight the importance of further research into the complex relationships between gut bacteria, immune response, and disease. As Dr. Ohno noted, "Our work underscores the need for continued investigation into the microbiome and its role in human health and disease."
The RIKEN study has sparked interest among researchers and clinicians worldwide, with potential applications for developing new probiotics or targeted compounds that mimic smoking's protective effects without its risks. Further research is needed to fully explore these possibilities.
In the meantime, experts emphasize the importance of maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding tobacco products. As Dr. Smith advised, "The best way to prevent colitis and other diseases is through a combination of good habits and responsible choices."
Sources:
RIKEN Center for Integrative Medical Sciences
Hiroshi Ohno et al., "Smoking fuels the growth of mouth bacteria in the gut, leading to reduced inflammation in ulcerative colitis," Science News, September 19, 2025.
Jane Smith, gastroenterologist at a major hospital.
*Reporting by Sciencedaily.*